BioSpace News Archive

First-of-its-kind patented privacy-preserving technology platform

Under the leadership of Isabelle de Cremoux, Health for Life Capital II™ builds upon its world-renowned experience in the microbiome field and its success with its first Health for Life Capital™ fund

RayStation has been chosen as the treatment planning system by The Oklahoma Proton Center.

VITALITY Study Demonstrates the Long-Term Durability of Patient Outcomes in Treating Symptomatic Uterine Fibroids

Epizyme, Inc., a clinical-stage biopharmaceutical company creating novel epigenetic therapies, announced that management will present at the following March investor conferences

Eli Lilly and Company announced that the U.S. Food and Drug Administration has granted Priority Review for its supplemental Biologics License Application for Emgality® injection for the preventive treatment of episodic cluster headache in adults.

Compugen Ltd. announced that John Hunter, PhD, Chief Scientific Officer, will present a corporate overview and update at the Cowen and Company 39th Annual Health Care Conference in Boston, on Monday, March 11, 2018, at 2:50 PM.

Saranas Inc., a medical device company with innovative technology for real-time detection and monitoring of internal bleeding during endovascular procedures, today announced that it has been granted de novo classification by the U.S. Food and Drug Administration (FDA) for the Early Bird Bleed Monitoring System.

ReForm Biologics, a privately-held pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced a collaboration with Astellas Pharma Inc.

Twist Bioscience Corporation announced that Emily Leproust, Ph.D., CEO and co-founder, will present at the 39th Annual Cowen Healthcare Conference on Tuesday, March 12th at 11:20 a.m.